Cite
Increased albumin quotient (QAlb) in patients after first clinical event suggestive of multiple sclerosis is associated with development of brain atrophy and greater disability 48 months later.
MLA
Uher, Tomas, et al. “Increased Albumin Quotient (QAlb) in Patients after First Clinical Event Suggestive of Multiple Sclerosis Is Associated with Development of Brain Atrophy and Greater Disability 48 Months Later.” Multiple Sclerosis (Houndmills, Basingstoke, England), vol. 22, no. 6, May 2016, pp. 770–81. EBSCOhost, https://doi.org/10.1177/1352458515601903.
APA
Uher, T., Horakova, D., Tyblova, M., Zeman, D., Krasulova, E., Mrazova, K., Seidl, Z., Vaneckova, M., Krasensky, J., Weinstock-Guttman, B., Ramanathan, M., Havrdova, E., & Zivadinov, R. (2016). Increased albumin quotient (QAlb) in patients after first clinical event suggestive of multiple sclerosis is associated with development of brain atrophy and greater disability 48 months later. Multiple Sclerosis (Houndmills, Basingstoke, England), 22(6), 770–781. https://doi.org/10.1177/1352458515601903
Chicago
Uher, Tomas, Dana Horakova, Michaela Tyblova, David Zeman, Eva Krasulova, Katerina Mrazova, Zdenek Seidl, et al. 2016. “Increased Albumin Quotient (QAlb) in Patients after First Clinical Event Suggestive of Multiple Sclerosis Is Associated with Development of Brain Atrophy and Greater Disability 48 Months Later.” Multiple Sclerosis (Houndmills, Basingstoke, England) 22 (6): 770–81. doi:10.1177/1352458515601903.